Skip to main content
. 2020 Feb 26;21:228. doi: 10.1186/s13063-020-4139-0

Table 3.

Consistency of findings when the same trial is examined in more than one clinical population

Condition and trial Clinical population Overall risk of bias Percentage excluded
Median percentage (range for Aaltonen and Vashisht)

Atrial fibrillation

ARISTOTLE (2011)

Yoon (record review for consenting patients in a single hospital)a High 32.3
Lee (primary care electronic medical record population data) Low 38.7
Fanning (record review within multiple hospitals) High 39.5
Desmaele (clinical registry in a single hospital) High 54.5
Hagg (primary care electronic medical record population data) Low 71.1

Atrial fibrillation

ROCKET-AF (2011)

Yoon (record review for consenting patients in a single hospital)a High 34.5
Lee (primary care electronic medical record population data) Low 52.5
Desmaele (clinical registry in a single hospital) High 60.7
Fanning (record review within multiple hospitals) High 64.2

Atrial fibrillation

RE-LY (2009)

Yoon (record review for consenting patients in a single hospital)a High 35.2
Lee (primary care electronic medical record population data) Low 36.2
Fanning (record review within multiple hospitals) High 47.4
Desmaele (clinical registry in a single hospital) High 52.4

Heart failure

MERIT-HF (2000)

Constantino (record review in a single hospital)a Unclear 48.0
Jost (clinical registry in a single hospital) Low 58.8
Masoudi (National Heart Failure Project registry) High 82.6

Heart failure

RALES (1999)

Masoudi (National Heart Failure Project registry)a High 74.7
Costantino (record review in a single hospital) Unclear 76.0

Acute myocardial infarction

GUSTO (1993)

Krumholz (National Research Registry of Myocardial Infarction)a High 84.5
Krumholz (Cooperative Cardiovascular Project registry) High 90.6

COPD

POET-COPD (2011)

Kruis (seven primary care databases)a High 77.0
Halpin (primary care research database) Low 88.2

COPD

UPLIFT (2009)

Kruis (seven primary care databases)a High 58.0
Halpin (primary care research database) Low 77.5

Rheumatoid Arthritis

9 trialsb

Aaltonen (National Register for Biologic Treatment)a High 80.0 (56.0 to 92.4)
Vashisht (RA Investigators’ Network database research registry) High 89.6 (74.7 to 91.6)
Vashisht (Veterans’ Affairs Rheumatoid Arthritis research registry) Unclear 97.4 (75.6 to 98.4)

Rheumatoid Arthritis

21 trialsb

Vashisht (RA Investigators’ Network database research registry)a Unclear 89.0 (64.9 to 93.5)
Vashisht (Veterans’ Affairs Rheumatoid Arthritis research registry) High 97.4 (72.7 to 99.1)

a Marked trials with most conservative estimate of percentage of patients excluded were analysed

b See supplementary table S14 for individual trial comparisons